To Treat or Not to Treat: Adjuvant Therapy for Stage II Colon Cancer in the Era of Precision Oncology
J Oncol Pract
.
2017 Apr;13(4):242-244.
doi: 10.1200/JOP.2017.022103.
Authors
Marios Giannakis
1
,
Kimmie Ng
1
Affiliation
1
Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
PMID:
28399380
DOI:
10.1200/JOP.2017.022103
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Colonic Neoplasms*
Combined Modality Therapy
Humans
Neoplasm Staging
Precision Medicine*